This inventor holds 1 USPTO granted patent. Top assignees: Brown University, Women and Infants' Hospital Rhode Island. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 492 
1 out of 2 Years Active: 2015
Title: Stayan Kalkunte: Innovator in Cancer Treatment
Introduction
Stayan Kalkunte is a notable inventor based in Barrington, Rhode Island, who has made significant contributions to the field of cancer treatment. His innovative work focuses on the synthesis and application of nitrofuran compounds, particularly Nifurtimox, which are aimed at treating cancer and inhibiting angiogenesis.
Latest Patents
Kalkunte holds 1 patent for his invention titled "Nitrofuran compounds for the treatment of cancer and angiogenesis." This patent is directed towards the synthesis and use of nitrofuran compounds as medicaments to treat cancer, especially neuroblastoma. The invention also encompasses compositions, unit dosage forms, and kits that include these compounds.
Career Highlights
Throughout his career, Stayan Kalkunte has worked with prestigious institutions such as Brown University and Women and Infants' Hospital Rhode Island. His research and development efforts have contributed to advancements in medical treatments and therapies.
Collaborations
Kalkunte has collaborated with notable professionals in his field, including Giselle L Saulnier Sholler and Narasimha Swamy. These collaborations have further enhanced the impact of his work in cancer research.
Conclusion
Stayan Kalkunte's innovative contributions to cancer treatment through his patented work on nitrofuran compounds highlight his dedication to advancing medical science. His collaborations and career achievements reflect his commitment to improving patient outcomes in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile